Trifecta Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History

Trifecta Capital Advisors, LLC

  • $658 Billion
  • Q3 2025

A detailed history of Trifecta Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 155 shares of ARKG stock, worth $4,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155
Previous 155 -0.0%
Holding current value
$4,167
Previous $3.78 Million 14.04%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025
SELL
$18.34 - $24.56 $5,685 - $7,613
-310 Reduced 66.67%
155 $3.78 Million
Q4 2022

Jan 17, 2023
BUY
$27.08 - $36.23 $12,592 - $16,846
465 New
465 $13.1 Million

Others Institutions Holding ARKG

# of Institutions
297
Shares Held
20.4M
Call Options Held
2.53M
Put Options Held
2.8M
View Full List

About ARK GENOMIC REVOLUTION ETF (DE

ARKG Quotes by TradingView
  • Ticker ARKG
  • Sector ETFs
  • Industry ETFs
More about ARKG
Track This Portfolio

Track Trifecta Capital Advisors, LLC Portfolio

Follow Trifecta Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trifecta Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trifecta Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email